Neoadjuvant chemoradiation for non-metastatic pancreatic cancer increases margin-negative and node-negative rates at resection. [electronic resource]
Producer: 20180807Description: 642-649 p. digitalISSN:- 1751-2980
- Adult
- Aged
- Aged, 80 and over
- Antimetabolites, Antineoplastic -- therapeutic use
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Chemoradiotherapy, Adjuvant
- Deoxycytidine -- administration & dosage
- Dose Fractionation, Radiation
- Drug Combinations
- Female
- Fluorouracil -- administration & dosage
- Humans
- Irinotecan
- Leucovorin -- therapeutic use
- Lymph Node Excision
- Lymph Nodes -- pathology
- Lymphatic Metastasis
- Male
- Margins of Excision
- Middle Aged
- Neoadjuvant Therapy
- Neoplasm, Residual
- Organometallic Compounds -- therapeutic use
- Organoplatinum Compounds -- therapeutic use
- Oxaliplatin
- Pancreatectomy
- Pancreatic Neoplasms -- diagnostic imaging
- Radiotherapy, Intensity-Modulated
- Retrospective Studies
- Survival Rate
- Tomography, X-Ray Computed
- Tumor Burden -- drug effects
- Gemcitabine
No physical items for this record
Publication Type: Comparative Study; Journal Article
There are no comments on this title.
Log in to your account to post a comment.